Table. Recommended doses and intervals between doses for human papillomavirus (HPV) vaccines, by age group at the start of the course

Age group

Recommended doses

Recommended schedule

Notes

Starting HPV vaccination at 9–14 years of age (except people who are immunocompromised)

2

0, 6–12 months

• The recommended age for HPV vaccination is 12–13 years, but people can receive vaccines from 9 years of age.
• If a person has received 2 doses of HPV vaccine with an interval of <5 months between dose 1 and dose 2, they need a 3rd dose at least 12 weeks after the 2nd dose. Ensure that the minimum intervals for 3 doses are met.
• If the 2nd dose is received <6 months but ≥5 months after the 1st dose, a 3rd dose is not required; clinical trial data support this interval still being sufficiently immunogenic.

Starting HPV vaccination at ≥15 years of age

3

0, 2, 6 months

• A 3-dose schedule of 0, 1 and 6 months for 2vHPV (2-valent HPV) vaccine is acceptable.

People who are immunocompromised at any age (excluding those with asplenia or hyposplenia)

3

0, 2, 6 months

• A 3-dose schedule of 0, 1 and 6 months for 2vHPV vaccine is acceptable.